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MATERNAL HEALTH-RELATED CAUSES OF CRANIAL NEURAL CREST  
 
CELL MIGRATION DYSREGULATION, AND THEIR COMMON CLINICAL  
 
EFFECTS 
 
MANVITA TATAVARTHY 
ABSTRACT 
 Neural crest cells arise during neurulation, a process that occurs during the third 
week of embryogenesis. These diverse cells then divide into various subtypes including 
cranial neural crest cells and cardiac neural crest cells. Each of these subtypes gives rise 
to a wide range of features throughout the fetus. While these cells are extremely diverse, 
they are also incredibly sensitive to their surrounding environment. Many maternal 
conditions affect neural crest cell division and migration, but maternal alcohol 
consumption and hyperglycemia due to gestational diabetes will be discussed in detail, 
with special attention paid to tissues that derive from cranial neural crest cells.  
 While the initial mechanisms of the pathology vary for both of these conditions, 
what is remarkable is that they ultimately cause effects in similar ways. Both mechanisms 
lead to the creation of reactive oxygen species, which in turn trigger apoptotic pathways. 
Neural crest cell death causes a variety of congenital anomalies in fetuses, including 
craniofacial defects and cardiac outflow tract defects. Treatment options that have been 
researched in both conditions also vary, but are based on similar principles. Antioxidant 
therapies reduce the production of reactive oxygen species, thus reducing the severity of 
the anomalies affecting the fetus during development.  
   
	 v	
Both maternal alcohol consumption and gestational diabetes are important public 
health concerns, and their management is of utmost priority in society. By decreasing the 
rates of women who consume alcohol during pregnancy, and managing gestational 
diabetes in those at highest risk, the rates of fetal congenital defects could be decreased.   
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INTRODUCTION 
A Brief Summary of Embryology 
To understand neural crest cells (NCC) and their pathologies, it is important to 
have a basic understanding of embryology. Following fertilization, the zygote undergoes 
multiple steps of cleavage. By three days post-fertilization, the embryo has reached the 
stage of a morula, containing 16 cells. Inner cells of the morula become the inner cell 
mass, or the actual embryo, and the outer cells form the trophoblast. After further 
divisions, the inner cell mass divides into the embryoblast. By day eight, the trophoblast 
develops into the inner cytotrophoblast and the outer syncytiotrophoblast. The 
embryoblast differentiates into the hypoblast and epiblast. The synctiotrophoblast is 
responsible for embedding and nourishment of the embryo, and eventually becomes the 
fetal portion of the placenta, while the inner layers continue differentiating to form the 
embryo itself (Sadler, 2012, Chapter 4).  
The third week of development is particularly significant, as it is the point at 
which gastrulation, the process of creating three germ layers, occurs. Once the primitive 
streak forms in the epiblast, cells migrate toward the primitive streak. At the primitive 
streak, cells undergo invagination. This process creates three germ layers – the endoderm, 
mesoderm and ectoderm. This is also the time at which the notochord forms from 
mesoderm in the cranial region. It should be noted that the ectoderm above the notochord 
differentiates into the neural plate at this time. Notably, the third week is an important 
stage as the mesoderm further differentiates into segments, or somitomeres (Sadler, 2012, 
Chapter 5). Each somite later differentiates into 3 components: the sclerotome, myotome 
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and dermatome via a complex signaling process involving proteins such as sonic 
hedgehog and Wnt (Sadler, 2012, Chapter 6).  
The end of the third week also leads to the process of neurulation, when the edges 
of the neural plate fold up to create neural folds and a neural groove (Sadler, 2012, 
Chapter 5). Neurulation happens in two stages – primary and secondary neurulation. 
Once the neural plate has folded into a tube, primary neurulation is comprised of the 
rostral part of the neural tube becoming the brain and the caudal part becoming the spinal 
cord. Secondary neurulation then proceeds in mammals. In this process, cells at the very 
caudal end aggregate into a caudal eminence, becoming the medullary cord. This cord 
eventually gives rise to the neural tube via secondary neurulation (ten Donkelaar, Bekker, 
Renier, Hori, & Shiota, 2014). While the neural tube forms, cells at the lateral border of 
the neural folds begin to separate and migrate away. These are the future NCC (Sadler, 
2012, Chapter 5). Figure 1 provides a visual demonstration of this process. 
  
 
Figure 1. Neurulation and neural crest cell separation. (A) Folding of neural plate into 
neural tube during neurulation. (B) Once neural tube has folded, most lateral cells begin 
to separate and migrate away to form neural crest cells. (C) Electron microscopy of 
processes of neurulation and neural crest cell separation (Sadler, 2012). 
 
A B C 
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Migration Patterns of Neural Crest Cells and Subtypes of Cells  
 As NCCs separate from the rest of the neural tube, they undergo an epithelial-to-
mesenchymal transition (EMT). This process is characterized by two main steps. The first 
occurs when epithelial cells lose their cellular polarity, and the second when they undergo 
detachment from neighboring cells through the downregulation of E-cadherins (Thiery, 
2003). While this process is not unique to NCCs, it is most relevant for these purposes.  
EMTs in NCCs are driven by fibroblast growth factor (FGF), Wnt, Notch, and 
retinoic signaling pathways (Thiery, Acloque, Huang, & Nieto, 2009). E-cadherin 
expression is regulated by zinc-finger transcription repression (Thiery, 2003), and is 
tightly associated with Snail transcription factors. Snail transcription factors have been 
found to repress the expression of E-cadherins, allowing for NCC to dissociate and 
migrate away from the neural tube. Snail was found to interact with the E-pal element of 
the E-cadherin promoter in a mouse model, and a corresponding element in humans 
(Cano et al., 2000). The mechanism of EMT will be discussed in greater detail in the 
following section. 
 NCCs can be classified into several cell types that give rise to unique features in 
the embryo. These include trunk neural crest cells (TNCC), vagal neural crest cell 
(VNCC) and sacral neural crest cells (SNCC), cranial neural crest cells (CNCC), and 
cardiac neural crest cells (CarNCC). While it is not a comprehensive list, Table 1 
describes some of the features that arise from each of these cell types. As this paper will 
focus on CNCC pathologies, special attention will be paid to tissues that arise from those 
cells. 
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Table 1. Neural Crest Cell Subtypes and a Selection of Derived Tissue Types. This 
table lists each subtype of neural crest cell and a selection of the tissues derived from 
these cell types (Hall, 2009). 
NCC Subtype Derived Tissue Types 
Trunk neural crest cells (TNCC) Merkel cells, Dorsal root ganglia, 
Chromaffin cells in adrenal medulla 
Vagal neural crest cells (VNCC) and 
Sacral neural crest cells (SNCC) 
Peripheral nervous system, Autonomic 
and parasympathetic nervous system, 
Schwann and glial cells, Enteric ganglia  
Cranial neural crest cells (CNCC) Mesenchyme, Connective tissue, 
Craniofacial cartilage and bone, Dentin, 
Parafollicular cells of the thyroid gland, 
Cornea, Ciliary muscle and muscles for 
eye attachment, Inner ear, Sensory ganglia 
of cranial nerves V, VI, IX, X 
Cardiac neural crest cells (CarNCC) Connective tissue for great vessels of 
heart, Heart septa, Smooth muscle of great 
arteries 
 
Epithelial-to-Mesenchymal Transition 
 EMT is a multistep process, with the first being the loss of cell polarity and the 
second being the loss of cell-to-cell adhesion through the downregulation of E-cadherins. 
It is an important process in many developmental stages, but it most relevant to this paper 
in the context of NCC differentiation and migration.  
 E-cadherin molecules make up the epithelial junctional complex to form tight 
junctions (Ikenouchi, Matsuda, Furuse, & Tsukita, 2003). The presence of tight junctions 
designates an apical and basolateral membrane to a cell, giving it polarity. Tight junctions 
are also necessary for preventing the inappropriate diffusion of molecules across 
membranes (Shin, Fogg, & Margolis, 2006).  
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EMT allows NCCs to separate from the rest of the contiguous tissue and migrate. 
Thus, EMT is dependent on the downregulation of E-cadherins. This downregulation is a 
carefully regulated process. The transcription factor Snail represses E-cadherin 
expression by binding to the E-cadherin promoter. As a zinc-finger transcription factor, 
Snail binds to the E-boxes in the E-cadherin promoter region. It is also known to regulate 
claudin and occludin synthesis through the same mechanism (Ikenouchi, Matsuda, 
Furuse, & Tsukita, 2003).  
Like Snail, another zinc-finger transcription factor involved in EMT is Slug. 
Slug’s regulation is what provides NCCs with their specialization and migratory ability. 
Slug has been found to only be expressed in migrating NCCs, and is not found in the cell 
before it is ready to begin its migratory process (Savagner, Karavanova, Perantoni, 
Thiery, & Yamada, 1998).  
 
Neural Crest Cell Differentiation and Migration 
 CNCCs give rise to various structures in the head and neck region, including 
sensory and autonomic ganglia as well as facial bone structures. Prior to migrating to 
their final site, and differentiating into CNCCs, NCCs must migrate from the neural tube. 
The neural tube is subdivided into rhombomeres, which dictate cell lineage and final 
differentiation. CNCC migration is unlike that of TNCCs, which is associated with 
molecules such as fibronecin, tenascin, and various other glycoproteins (Thiery, Duband, 
& Delouvée, 1982). Instead, rhombomeres segregate based on segmental specification. 
Most of these cells then migrate through the rostral half of the dorsal sclerotome and exit 
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at the level of their specified rhombomere. This allows for differentiation of cells and the 
creation of the specified structure (Lumsden, Sprawson, & Graham, 1991). Notably, 
CNCCs begin migration as sheets of cells, for the first 3-5 hours of migration. They then 
begin to lose intercellular adhesion and migrate individually (Alfandari, Cousin, & 
Marsden, 2010). On the other hand, TNCCs migrate as individual cells from the 
beginning (Czarnobaj, Bagnall, Bamforth, & Milos, 2014). Figure 2 will demonstrate the 
seven rhombomeres of CNCCs and their derived structures in the head and neck region. 
 
 
Figure 2. Segmental specification of rhombomeres to form structures derived from 
cranial neural crest cells. The neural crest cells of the embryo can be divided into seven 
rhombomeres, each of which migrates and develops into specific structures in the head 
neck (Gong, 2014). 
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Cranial Neural Crest Cell Differentiation 
 Once NCCs have undergone EMT, they are free to migrate to their specified sites. 
Some NCCs specifically become CNCCs that later go on to form cranial features. This 
differentiation is mediated by Sonic hedgehog (Shh) signaling, shown by one group to be 
required for CNCC participation in jaw development. In Shh knockout cells, CNCCs 
underwent apoptosis and did not form the appropriate structures (Brito, Teillet, & Le 
Douarin, 2006). This has since been confirmed in multiple studies showing the necessity 
of Shh signaling in the development of various structures derived from CNCCs such as 
the first pharyngeal arch (Yamagishi et al., 2006) as well as other craniofacial structures 
(Ahlgren & Bronner-Fraser, 1999).  
 Shh is a protein that plays a critical role in cell patterning at various stages of 
embryological development. Among other processes, Shh has been shown to drive 
sclerotome formation from somites. Shh protein acts through the Patched (Ptc) 
transmembrane receptor (Ahlgren & Bronner-Fraser, 1999). Ptc homologues were first 
identified in Drosophila, and then in mice. In mice, it was noticed that the expression of 
each homologue was specific to the tissue type, indicating specialization of function 
(Motoyama et al., 1998).  
 
Development of Tissues Derived from CNCCs and CNCC Migration 
 Unlike Shh which has a role in the patterning process, Wnt signaling was thought 
to solely regulate cellular expansion by acting as a mitogen (Ikeya, Lee, Johnson, 
McMahon, & Takada, 1997). However, it has more recently been shown that Wnt 
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signaling can actually also specify NCC fate. It is needed for processes such as contact 
inhibition of locomotion (CIL) and collective chemotaxis, indicating its importance in 
NCC migration (Maj et al., 2016).  
 CIL is a process through which cells use contact signaling to change direction of 
migration. During EMT, expression of cadherins switches from E-cadherin to N-
cadherin, such that chemokines can provide direction for cell migration (Bahm et al., 
2017). As neurulation progresses, cadherin expression slowly shifts from E-cadherins, to 
N-cadherins. By the time the neural tube closes, E-cadherin expression is negligible, with 
N-cadherins being primarily expressed (Nakagawa & Takeichi, 1995). In mouse models, 
N-cadherin knockout mice showed abnormal somite migration. However, unlike in vitro 
models, some migration did occur, suggesting that other adhesion molecules were able to 
take over. One such suggested molecule is cadherin-6 (Radice et al., 1997). Chemotaxis 
is mediated by the platelet-derived growth factor (PDGF) receptor tyrosine kinase 
pathway that has been shown to be necessary in NCC proliferation, migration and EMT 
(Bahm et al., 2017). Studies in Xenopus have further shown that expression of cadherin-
11 is required as the cell-cell adhesion molecule for CIL and collective migration. When 
the adhesive function of cadherin-11 was blocked in experiments, improper migration 
resulted. When cadherin-11 was overexpressed, migration of CNCCs was inhibited 
altogether (Becker, Mayor, & Kashef, 2014).  
 In vitro studies of NCC migration show that NCC populations invade mesoderm 
and ectoderm layers, but do not invade other NCC populations that are migrating in the 
opposite direction. In fact, when NCC populations encounter other populations of NCCs, 
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they penetrate deeper into mesodermal tissue. The same group confirmed these results in 
vivo and found similar results, further supporting the concept of CIL (Carmona-Fontaine 
et al., 2008).  
NCC migration is dependent on actin filament interactions with the cytoskeleton. 
The gene capzb was initially identified through whole-genome sequencing in a patient 
with micrognathia, cleft palate, and hypotonia – all features associated with dysregulation 
of CNCC. Once the gene was identified, the group studied the protein in a zebrafish 
model. This gene encodes an actin-capping protein that binds to the growing end of F-
actin and caps it in order to regulate cell locomotion. In capzb knockout individuals, 
CNCC migration was not possible and a phenotype similar to that of the patient in which 
the gene was identified resulted (Mukherjee et al., 2016). In a prior study by a different 
group, it was found that CNCCs undergo apoptosis when the actin-cytoskeleton 
interaction is interrupted (Hinoue Atsushi et al., 2005).  
 The process of induction to form specialized cells such as osteoblasts or 
chondroblasts has also been studied in great detail. Mandibular and maxillary bone, two 
craniofacial bones derived from CNCCs, form when mandibular and maxillary epithelia 
signals mandibular and maxillary mesenchyme and induces it to form osteoblasts. These 
osteoblasts then undergo intramembranous ossification to form structures (Hill, Yuasa, 
Schoenecker, & Goudy, 2014). In addition to craniofacial bones, it should be noted that 
CNCCs give rise to many other structures, such as some cells and tissues of the tooth 
including dental papilla and odontoblasts, through similar signaling pathways like Wnt1 
(Chai et al., 2000).  
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Importance of Understanding the Effects of Maternal Health on the Fetus 
 Teratogens are endogenous or exogenous compounds that can cause 
developmental issues in the embryo, and have significant effects. Examples of teratogens 
that will be discussed in this work are alcohol and maternal hyperglycemia. Fetal 
development is a tightly regulated process that is time-sensitive and embryogenesis is 
defined by various critical periods. For example, fetal exposure to ethanol on gestational 
day (GD) 7 to 7.5 caused apoptosis in the neuroectoderm, as most embryos undergo 
gastrulation by this stage. However, by GD 8, apoptosis is seen specifically in the 
neuroectoderm, and by GD 8.5, specifically in surface ectoderm (Dunty, Chen, Zucker, 
Dehart, & Sulik, 2001). At very early stages, cell death of an entire germ layer would 
cause massive consequences to the phenotype. In the case of fetal alcohol exposure, 
fetuses that were exposed to ethanol at gastrulation or neurulation underwent apoptosis of 
entire cranial NCC populations, whereas fetuses that were exposed to ethanol at somitic 
stages, as little as eight days post-conception, only underwent apoptosis in caudal cell 
populations, resulting in less severe damage (Cartwright & Smith, 2006).  
 Another teratogen known to cause CNCC defects is maternal hyperglycemic 
conditions. It has been shown that excessive hyperglycemia during gestation prevents 
CNCC from proliferating (Wang et al., 2016). In a clinical setting, maternal 
hyperglycemia can be managed. As suggested previously, proper maternal education 
during pregnancy can prevent severe fetal effects caused by this condition.  
Understanding the ways in which maternal behavior affects the development of 
the fetus is essential from a public health standpoint.  
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While maternal alcohol consumption and maternal hyperglycemia begin through 
separate mechanisms, they both ultimately trigger NCC apoptosis, and cause similar 
effects in the fetus. Understanding the similarities between these conditions and the fetal 
effects they cause is important from a clinical perspective, as they provide an 
understanding of high-risk pregnancies. This literature review will examine current 
studies related to fetal effects on CNCC-derived structures as a result of exposure to 
alcohol and maternal hyperglycemia in utero. 
 
Specific Aims and Objectives 
• Examine the mechanisms of cranial neural crest cell migration and their dysregulation 
• Explore the embryology and clinical effects of specific fetal syndromes related to 
cranial neural crest cell migration dysregulation  
• Correlate syndromes of cranial neural crest cell migration defects with maternal 
health related causes 
• Discuss public health implications of maternal behavior and health during pregnancy 
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MATERNAL ALCOHOL CONSUMPTION 
 
Fetal Alcohol Syndrome 
 One teratogen that will be examined in this paper is maternal alcohol 
consumption. Fetal alcohol syndrome, a collection of phenotypes associated with 
maternal alcohol consumption during gestation, has been studied in great detail. Alcohol 
is a low molecular weight drug, and is able to pass from maternal circulation to the fetus 
via the placenta at levels such that alcohol concentrations are roughly equal in maternal 
and fetal blood. The first step of alcohol metabolism is the breakdown of alcohol to 
acetaldehyde by alcohol dehydrogenase, in the liver. Acetaldehyde is cytotoxic, 
mutagenic and interferes with microtubular structure during mitosis, causing 
chromosomal abnormalities. While alcohol has been shown to have direct negative 
effects on embryological development, the development of fetal alcohol syndrome is 
thought to be primarily mediated by acetaldehyde (Kumar, 1982).  
Gestational exposure to ethanol is known to cause craniofacial deformities in the 
fetus, presumably by affecting CNCC development and migration (Zhang et al., 2017). 
Effects of alcohol on various cell types have been compared in multiple studies. Some of 
the earliest research established that neural tissue and craniofacial bones are most 
severely affected by maternal alcohol consumption (Clarren, Alvord, Sumi, Streissguth, 
& Smith, 1978). More recent groups have delved into alcohol’s effects on these 
structures, and have focused on using them as diagnostic tools for fetal alcohol syndrome 
(Shen et al., 2013). Further research has shown that class IV alcohol dehydrogenase is 
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localized to CNCCs in the craniofacial region after neural tube closure. This has 
important implications in why maternal alcohol consumption so severely affects 
craniofacial bone (Ang, Deltour, Hayamizu, Žgombic-Knight, & Duester, 1996).  
Craniofacial bones are formed by intramembranous ossification as CNCC-derived 
cells migrate inward and differentiate into osteoblasts (Zhang et al., 2017). To begin the 
process of craniofacial bone development, CNCCs migrate ventrolaterally until they 
make contact with pharyngeal ectoderm and endoderm. Once this occurs, CNCCs 
proliferate and form branchial arches. CNCCs from rhombomeres 1, 2 and 3 migrate into 
the first branchial arch, where they receive signals to regain polarity. This polarity orders 
the cells from maxillary to mandibular prominences (Huang & Thesleff, 2013). Without 
the inward migration of these cells, craniofacial bones are unable to form, leading to 
observable defects in facial features. It should also be noted that fetal alcohol syndrome 
includes a collection of other symptoms including, but not limited to, microcephaly, 
cardiac abnormalities, neurodevelopmental impairment, short stature, and seizures (Jones 
& Smith, 1975). While these symptoms have extremely important effects on patients’ 
lifestyles, most pertinent to this discussion are the effects on craniofacial structures, due 
to the involvement of CNCCs. Figure 3 demonstrates common craniofacial abnormalities 
that have been associated with fetal alcohol syndrome.  
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Figure 3. Craniofacial features characteristic of fetal alcohol syndrome. This image 
shows a variety of craniofacial deformities that are commonly indicative of fetal alcohol 
syndrome (Warren, Hewitt, & Thomas, 2011). 
 
 
 Early studies of the effects of acetaldehyde on fetal development show 
acetaldehyde to be a teratogen, causing growth defects in the very preliminary days of 
gestation (day 10). Acetaldehyde was shown to cause failure of neural tube closure, thus 
leading to many of the issues associated with fetal alcohol syndrome. It has been shown 
to have dose-dependent effects (O’Shea & Kaufman, 1979), although not all fetuses 
exposed to alcohol in utero develop fetal alcohol syndrome (Popova, Lange, Probst, 
Gmel, & Rehm, 2017). The intricacies of whether or not a fetus will develop congenital 
defects after exposure to alcohol in utero are not yet completely understood, leaving this 
open for future studies to examine. An understanding of the mechanisms that trigger 
effects in some fetuses and not others would be a valuable tool for clinicians. 
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Alcohol’s Effects on Cranial Neural Crest Cell Migration and Pathogenesis of Fetal 
Alcohol Syndrome 
 A recent study examined alcohol’s effects on craniofacial structures through its 
direct dysregulation of CNCC migration through the dysregulation of EMT. With ethanol 
treatment, CNCCs upregulate cadherin 6B, a molecule that is usually downregulated in 
normal CNCC migration. The downregulation of cadherin 6B is normally necessary for 
CNCC EMT. Other adhesion molecules found to be up-regulated include laminins and N-
cadherins. The upregulation of these molecules further prevents the conversion of 
CNCCs into migratory cells. The regulation of N-cadherin and cadherin 6B expression is 
through the transcription factor Slug (Zhang et al., 2017). In in vitro studies, ventral 
migration was also found to be inhibited, with CNCCs seen to be amassing dorsally, 
when exposed to alcohol (Shi et al., 2014). Figure 4 describes several pathways that are 
disrupted by alcohol, leading to abnormalities in NCC development.  
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Figure 4. Summary of ethanol’s effects on cranial neural crest cell development and 
migration. This image demonstrates the various pathways through which alcohol 
exposure disrupts neural crest cell development, thus causing craniofacial bone defects 
(Zhang et al., 2017). 
  
 
Perhaps most importantly in the development of the craniofacial morphology 
characteristic of fetal alcohol syndrome, ethanol has been found to push CNCCs toward 
apoptosis. Ethanol causes oxidative stress in CNCCs, eventually triggering the apoptotic 
pathway. It has been found to decrease Bcl-2 levels, an anti-apoptotic protein. 
Additionally, it has been shown to increase p53 expression (Wentzel & Eriksson, 2009). 
The mechanism through which apoptosis is triggered has been studied in great detail. 
Chronic alcohol users have been found to have increased iron uptake at the intestinal 
expressions in the cranial neural tube of control and ethanol-treated
embryos. A1-D1: Transverse sections of the stained embryos at the le-
vels indicated by the dotted lines in A2-D2: Higher magnification of
regions indicated by dotted squares in A1-D1, respectively. E-F: Bar
charts comparing the size of Msx1+ (E) and BMP4+ (F) areas in
transverse sections of control and ethanol-treated embryos. G: RT-qPCR
analysis indicating the extent of Msx1 and BMP4 expressions, normal-
ized against GAPDH. Scale bars = 200 μm in A-D; 50 μm in A1-D1 and
50 μm in A2-D2.
In situ hybridization and RT-qPCR analysis were also performed for
Slug and FoxD3 expressions. It was found that ethanol treatment sig-
nificantly down-regulated the expression of both genes in the dorsal
neuroepithelium (Slug: control: 1.00 ± 0.04, n = 3; alcohol:
0.28 ± 0.03, n = 3; p < 0.001; FoxD3: con: 1.00 ± 0.05, n = 3;
alcohol: 0.38 ± 0.36, n = 3; p < 0.01; Fig. 9G). These results suggest
that ethanol exposure impedes EMT by de-regulating the expression of
up-stream transcription factors (Thiery and Sleeman, 2006).
A–B: Representative micrographs of Slug and FoxD3 expressions in
the cranial regions of control and ethanol-treated embryos. A1−D1:
Transverse sections of stained embryos at the levels indicated by the
dotted lines in A−D. A2-D2: Higher magnification of regions indicated
by dotted squares in A1-D1, respectively. E-F: Bar charts comparing the
size of Slug+ (E) and FoxD3+ (F) areas in transverse sections of control
and ethanol-treated embryos. G: RT-qPCR analysis showing the extent
of Slug and FoxD3 expressions, normalized against GAPDH. Scale
bars = 200 μm in A-D; 50 μm in A1-D1 and 25 μm in A2-D2.
4. Discussion
Consumption of alcohol during pregnancy is now recognize as a
potential teratogenic risk and FAS is the most severe developmental
defect that could arise as a consequence (Gupta et al., 2016).
Fig. 9. Effects of ethanol on Slug and FoxD3 expressions in the neural tube.
Fig. 10. Hypothetical model illustrating how ethanol exposure induces cranial neural
crest cell dysplasia.
P. Zhang et al. 7R[LFRORJ\/HWWHUV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mucosa (Duane, Raja, Simpson, & Peters, 1992). While this addresses increased iron 
levels in the maternal tissue, it has also been shown that alcohol consumption during 
gestation increases fetal iron levels as well (Chen & Sulik, 2000). Furthermore, ethanol 
metabolism, and the subsequent depletion of NADH stores causes iron to be freed from 
intracellular stores, further increasing blood iron concentration. Due to oxidative stress, 
iron then leads to the formation of hydroxyl radicals, which induces apoptosis once 
cellular integrity is compromised (Nordmann, Ribière, & Rouach, 1992).  
 
Folic Acid Deficiency and its Effects on Cranial Neural Crest Cell Apoptosis 
 CNCC dysregulation in fetal alcohol syndrome has also been shown to be linked 
to increased levels of maternal serum homocysteine (hyperhomocysteinemia), due to 
folate deficiency. Adequate folic acid levels have been shown to be crucial in pregnancy, 
for many reasons including folate’s importance in hematopoiesis (Henry et al., 2017). 
Folate deficiencies have been found to cause megaloblastic anemia in pregnancy, leading 
to congenital birth defects (Chanarin, Rothman, Ward, & Perry, 1968). During 
pregnancy, folate requirements are elevated, and adequate folate levels are essential to the 
prevention of neural tube defects (Christensen & Rosenblatt, 1995). Deficiencies in folic 
acid and vitamin B12 prevent adequate activity of methionine synthase, resulting in 
elevated serum levels of homocysteine and deficiencies in methionine (Kirke et al., 
1993). Via the placenta, homocysteine can enter amniotic fluid from the mother 
(Steegers-Theunissen et al., 1995). Because NCCs are unable to properly handle 
oxidative stress, the generation of reactive oxygen species by ethanol and acetaldehyde 
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cause apoptosis in CNCCs. Homocysteine is readily oxidized to homocystine in the 
blood, generating hydrogen peroxide (H2O2), superoxide ions (O2-) and other ROS. These 
compounds trigger apoptosis in many cell types including endothelial cells (Starkebaum 
& Harlan, 1986), and NCCs (Knott, Hartridge, Brown, Mansell, & Sandy, 2003).  
 
Prevalence, Prevention, Screening and Diagnosis of Fetal Alcohol Syndrome 
 The relationship between maternal alcohol consumption during gestation and the 
incidence of fetal alcohol syndrome has been clearly demonstrated for years. In a study 
conducted by the Center for Disease Control (CDC) in 2012, it was found that 51.5% of 
non-pregnant women between the ages of 18-44 (including those women who are of 
child-bearing age) used alcohol within 30 days of being surveyed. More importantly, 
about 7.6% of pregnant women in the same age range used alcohol in that period. 
Amongst those pregnant women, the highest report of alcohol use was in women aged 
35-44 years at 14.3%, white females at 8.3%, college graduates at 10%, and employed 
women at 9.6%. Notably, this study found that pregnant and non-pregnant binge drinkers 
consumed alcohol at the same frequency and intensity. The CDC continues efforts to 
incorporate education into clinical practice and community interventions in order to 
further bring these numbers down. The CDC has created questionnaires for use by family 
practitioners and obstetricians in their regular screenings among women of childbearing 
age. It has also pushed for the creation of public health policies that increase alcohol 
excise taxes in an effort to reduce alcohol consumption, and therefore misuse (Center for 
Disease Control and Prevention, 2012). Through a meta-analysis examining data from 
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studies conducted all over the world, one team was able to conclude that about one in 67 
women who consumes alcohol while pregnant gives birth to a child with fetal alcohol 
syndrome (Popova et al., 2017). While the consumption of alcohol during pregnancy 
does not lead to fetal alcohol syndrome in every case, the implications remain extremely 
serious.  
 Currently in use are two screening questionnaires – TWEAK and T-ACE 
(Russell, 1994). In one study, these questionnaires, plus two more that are commonly 
used in traditional alcoholism screening, the MAST and CAGE, were compared for their 
efficacy in predicting whether mothers were at risk of drinking alcohol during pregnancy. 
The study found that TWEAK, a combination of T-ACE, MAST and CAGE, was 
effective, but that T-ACE was most effective when paired with MAST and CAGE 
screening tools (Russell et al., 1996). TWEAK measures five items and each item is 
described as such:  
T – “Tolerance – How many drinks can you hold?” 
W – “Worried - Have close friends or relatives worried or complained about your 
drinking in the past year?” 
E – “Eye opener – Do you sometimes take a drink in the morning when you first get up?” 
A – “Amnesia – Has a friend or family member ever told you about things you said or did 
while you were drinking that you could not remember?” 
K(C) – “Cut down – Do you sometimes feel the need to cut down on your drinking?” 
(Russell, 1994).  
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 Because symptoms can occur along a wide range, diagnosis of fetal alcohol 
syndrome can sometimes be difficult. However, proper diagnosis is important for many 
reasons, including proper patient care, and collection of proper statistics to calculate 
prevalence. Thus, in 2000, a group in Washington created the 4-Digit Diagnostic Code. 
This classification system includes four components – growth component, facial 
phenotype component, brain damage/dysfunction component and gestational alcohol 
exposure component. In each of these components, the patient can receive a score of 1 to 
4, resulting in a combined score ranging anywhere from 1111 to 4444. The results of this 
score places a patient within the fetal alcohol syndrome and related fetal alcohol 
spectrum disorders scale (Astley & Clarren, 2000). Figure 5 is a demonstration of a 
hypothetical scoring code grid that is used by clinicians.  
 
 
Figure 5. Example of 4-Digit Diagnostic Code. This figure provides example of the 
way in which a score is calculated in each of the four categories to give an overall 
composite score, leading to a diagnosis (Astley & Clarren, 2000). 
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While less common from a clinical perspective, other methods of diagnosis have 
been suggested as well. For example, the use of maternal blood markers to detect whether 
or not the fetus has been exposed to teratogenic levels of alcohol could be useful in 
determining risk (Stoler et al., 1998). A more common prenatal method of diagnosing 
fetal alcohol syndrome is through ultrasound. Detection of facial abnormalities and 
reduced frontal cortex size in fetuses with prenatal alcohol exposure can be an indication 
of fetal alcohol syndrome (Montag et al., 2016). Early detection and subsequent proper 
diagnosis are essential to ensuring proper treatment. Children with fetal alcohol syndrome 
are faced with a lifetime of issues including neurodevelopmental impairment and a 
variety of physical abnormalities (Jones & Smith, 1975). Thus, early detection of these 
conditions allows medical professionals to treat patients accordingly. Additionally, a 
proper understanding of the prevalence of fetal alcohol syndrome in various communities 
can allow professionals to create policy and public health interventions that are directed 
at decreasing alcohol exposure among women of childbearing age.  
 
Potential Treatments  
 If a primary cause of CNCC apoptosis due to alcohol exposure is oxidative stress, 
potential treatments should ideally aim to prevent this. One study suggests that the 
compound sulforaphane, found abundantly in broccoli and similar vegetables, provides 
antioxidant benefits. Sulforaphane has been found to act through the Nrf2 signaling 
pathway that is normally involved in ethanol-induced apoptosis (Chen, Liu, & Chen, 
2013). A transcription factor that regulates enzymes such as superoxide dismutase (SOD) 
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and catalase involved in the antioxidant response, and protects cells against damage and 
apoptosis, Nrf2 is upregulated by reactive oxygen species (Nguyen, Sherratt, Nioi, Yang, 
& Pickett, 2005). According to the study on sulforaphane, suppressing the Nrf2 signaling 
pathway suppressed sulforaphane’s protective effects on CNCCs, further proving the 
necessity of this mechanism. Thus, consuming vegetables such as broccoli, especially in 
pregnant women with a history of chronic alcohol abuse, can provide a protective 
mechanism against the damage caused by reactive oxygen species that leads to the 
symptoms of fetal alcohol syndrome (Chen et al., 2013). In a research setting, adding 
SOD, an antioxidant enzyme, also decreased the production of reactive oxygen species 
and decreased the incidence of fetal defects (Wentzel & Eriksson, 2009).  
 Another important finding in the mechanism of CNCC dysregulation in fetal 
alcohol syndrome is maternal hyperhomocysteinemia due to folate deficiency. 5-
methyltetrahydrofolate has been found to decrease homocysteine levels, and prevent 
many of its detrimental effects such as CNCC apoptosis dysregulation of migration (Shi 
et al., 2014). Additionally, exogenous folic acid and vitamin B12 supplementation in 
pregnant women has been found to decrease homocysteine levels (Xu et al., 2006).  
 Children born with fetal alcohol syndrome also commonly experience 
neurodevelopmental abnormalities, leading to behavioral issues and learning delays. 
Executive function, or the ability to plan, regulate actions, and monitor one’s own 
behavior (Chan, Shum, Toulopoulou, & Chen, 2008), is affected in these children. Thus, 
these symptoms must also be considered in their management. Studies have found that 
neurocognitive habilitation programs, such as the Alert program, are in fact effective in 
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improving executive functioning in children with fetal alcohol syndrome. This program 
helps children become more cognizant of their own behavior by helping them identify 
their arousal level, and altering their behavior accordingly. The goal of this program, and 
others like it, is to provide children with the tools to monitor their own behavior (Wells, 
Chasnoff, Schmidt, Telford, & Schwartz, 2012).  
 
MATERNAL GESTATIONAL DIABETES 
 
Gestational Pre-Diabetes and Diabetes Mellitus 
 The World Health Organization (WHO) has classified levels of hyperglycemia 
during pregnancy into various categories. According to the WHO, mothers who are 
hyperglycemic during pregnancy should be diagnosed with one of the following – 
“Diabetes mellitus in pregnancy” or “Gestational diabetes mellitus.” Diagnosis should be 
based on if the patient meets certain values in one or more of these tests – fasting plasma 
glucose, 2-hour plasma glucose, or random plasma glucose (World Health Organization, 
2013). For the purposes of this thesis, only gestational diabetes mellitus (GDM) will be 
considered.  
Incidence of GDM varies between various ethnic groups, with some having a 
higher risk than others. One group’s meta-analysis estimated the number of cases of 
hyperglycemia in pregnancy based on world region. Table 2 describes the prevalence of 
hyperglycemia during pregnancy in various geographic regions. (Guariguata, 
Linnenkamp, Beagley, Whiting, & Cho, 2014). 
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Table 2. Prevalence of Hyperglycemia in Pregnancy Separated by Geographic 
Region. Prevalence of hyperglycemia in pregnancy calculated by dividing the cases of 
hyperglycemia in pregnancy by the number of live births reported in each world region. 
Adapted from Global Estimates of the Prevalence of Hyperglycaemia in Pregnancy 
(Guariguata et al., 2014) 
Region Prevalence (Cases of hyperglycemia in 
pregnancy/Number of live births) 
Africa (Nigeria) 16.0% 
Europe 15.2% 
Middle East/North Africa 22.3% 
North America 13.2% 
South America (Argentina, Brazil, Cuba) 13.2% 
South Asia 23.1% 
Western Pacific (Australia, China, Japan, 
Malaysia, Singapore, Thailand, Vietnam) 
11.8% 
 
 
Amongst the potential causes of GDM, much attention has been given to maternal 
weight gain during pregnancy. One study conducted in a population of pregnant women 
in Wisconsin found that women who entered pregnancy with obesity were more likely to 
gain unhealthy amounts of weight during pregnancy (Lindberg et al., 2016). In addition 
to maternal weight, other risk factors include maternal age, a history of spontaneous 
abortions, family history of diabetes, persistent glucosuria, polycystic ovary syndrome 
(PCOS) and GDM in a previous pregnancy (Brown, 2016). Table 3 summarizes common 
risk factors that have been identified in patients with GDM. It also identifies a protective 
factor that has been shown to reduce the risk of developing GDM.  
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Table 3. Summary of Risk Factors and Protective Factors Associated with 
Gestational Diabetes Mellitus. A summary of risk factors and protective factors that 
have been associated with the occurrence of gestational diabetes mellitus. Adapted from 
Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes 
(Ben-Haroush A., Yogev Y., & Hod M., 2004).  
Maternal Factors Advanced maternal age, high parity, pre-
pregnancy weight, pregnancy weight gain, 
BMI 27, short stature, low birth weight, α-
thalassemia trait, polycystic ovary 
syndrome, high intake of saturated fat 
Family History Family history of diabetes, GDM in 
woman’s mother 
Previous Obstetric Outcome Congenital malformation, stillbirth, 
macrosomia, caesarean section, previous 
GDM 
Pregnancy Factors Congenital malformation, multiple 
pregnancy, increased iron stores 
Protective Factors Young age 
 
 
 Pregnancy normally results in decreased insulin sensitivity through multiple 
mechanisms (Catalano, Tyzbir, Roman, Amini, & Sims, 1991). One such cause is 
hormonal. In a study conducted in a dog model, elevated levels of progesterone and 
estradiol, as seen during pregnancy, were studied. It was found that these hormones, 
along with placental hormones, decreased cells’ sensitivity to counterregulatory 
hormones such as glucagon, epinephrine, norepinephrine, and growth hormone (Batista et 
al., 2005). Another hormone known to be produced at higher levels during pregnancy is 
leptin. While leptin production is usually associated with adipose tissue, the hormone has 
also been found to be produced by the placenta (Masuzaki et al., 1997). Leptin levels 
have been shown to correlate positively with BMI, and high leptin levels have been 
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shown to be predictive of development of GDM (Soheilykhah, Mojibian, Rahimi-
Saghand, Rashidi, & Hadinedoushan, 2011). 
Another mechanism known to decrease insulin sensitivity during pregnancy is 
inflammation. Pregnancy is pro-inflammatory, with decreased TNF-α levels in early 
pregnancy and increased production as pregnancy progresses into the third trimester. This 
change in TNF-α levels is inversely related to insulin sensitivity – as TNF-α levels 
increase, insulin sensitivity decreases (Kirwan et al., 2002). TNF-α has been found to 
downregulate IRS-1, an important protein that mediates insulin receptor tyrosine kinase 
activity (Hotamisligil, Murray, Choy, & Spiegelman, 1994).  
 While most risk factors associated with GDM are either intrinsic to pregnancy, or 
are based on environmental factors that surround the mother, GDM has also been found 
to have genetic components. It has long been understood that maternal glucose 
metabolism should adapt during pregnancy to adjust for both maternal and fetal needs. 
How this occurs is better understood through the identification of two particular genes, 
BACE2 and HKDC1, that were only found to be expressed in pregnant cohorts (Hayes et 
al., 2013). Figure 6 shows the integration of multiple mechanisms that can eventually 
lead to GDM. 
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Figure 6. Model of Integration of Mechanisms Leading to GDM. This model 
integrates the numerous mechanisms that work synergistically to cause GDM in pregnant 
women (Abell, De Courten, Boyle, & Teede, 2015).  
 
GDM-Induced Hyperglycemia and its Effects on Neural Crest Cells 
 Initially identified in rats, GLUT1 transporters have been found on the placental 
barrier in syncytiotrophoblast cells. The combination of gap junctions and glucose 
transporters allows for glucose to be transported from maternal blood to the fetus via the 
placenta (Takata, Kasahara, Kasahara, Ezaki, & Hirano, 1994). In diabetic pregnancies, 
GLUT1 transporter expression in the placenta has been shown to be increased two-fold. 
This indicates that hyperglycemia in the mother will lead to hyperglycemic conditions for 
the fetus as well (Gaither, Quraishi, & Illsley, 1999). Hyperglycemic conditions have 
long been shown to cause fetal macrosomia. Fetuses of GDM pregnancies have been 
found to be hyperinsulinemic. Glucose crosses the placental barrier and is a secretagogue, 
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triggering fetal pancreatic β-cells hyperplasia and hypersecretion of insulin. In primate 
studies, hyperinsulinemia was shown to cause hyperplasia and hypertrophy, particularly 
of soft tissue organs such as the liver, spleen and heart, leading to macrosomia (Susa & 
Schwartz, 1985). This has been confirmed in later studies in a fetal rat model. Injection of 
insulin increased rates of protein synthesis in these tissues, but did not affect rates of 
protein breakdown (Johnson et al., 1990). More recent studies have examined the effects 
of fetal hyperinsulinemia to better understand the mechanism of macrosomia. It has been 
found that hyperinsulinemia in the fetus leads to higher rates of farnesylation of p21-Ras, 
a key checkpoint in mitosis. Increased farnesylation indicates increased rates of mitosis, 
promoting growth of these tissues (Thureen et al., 2006).  
 The mechanism by which GDM affects NCCs has best been described in 
CarNCCs, even though it is similar in CNCCs as well (Eriksson & Borg, 1993). One of 
the ways in which maternal hyperglycemia acts as a teratogen in fetuses is via oxidative 
stress. Increased levels of glucose call for increased mitochondrial activity. This results in 
higher rates of electron transport chain activity, and other oxidative mechanisms, 
ultimately leading to an increased production of ROS. The same study to identify this 
phenomenon was also among the first to associate the production of ROS with incidences 
of congenital defects. By adding SOD, an antioxidant enzyme, the experimenters were 
able to decrease the rate of occurrence of the defects, thus implying a correlation between 
the production of ROS and of the likelihood of the fetus developing a congenital defect 
(Eriksson & Borg, 1993). Another study found that the two main pathways of DNA 
damage repair, the Ataxia-telangiectasia mutated-checkpoint 2 (ATM-Chk2) and ATR-
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Rad3-related-checkpoint 1 (ATR-Chk1) were more likely to be elevated in the embryo. 
Also shown to be elevated was the cell-cycle check point p53, under maternal 
hyperglycemic conditions. Together, these two features indicate that maternal 
hyperglycemia causes increased amounts of DNA damage in the embryo (Dong et al., 
2015).  
 Interestingly, recent research has revealed some new findings in this field of 
study. Two separate groups have been able to find a correlation between GDM and 
upregulation of autophagy in placental tissue as a mechanism of pathogenesis in the fetus 
(Avagliano et al., 2017). One group went further to correlate the generation of oxidative 
stress in fetuses of diabetic pregnancies with the increased levels of autophagy (Ji et al., 
2017).   
 Unlike fetal alcohol syndrome, GDM does not always cause a predictable 
constellation of congenital defects. However, in addition to macrosomia, meta-analysis 
studies have found a wide range of congenital defects that have been associated with 
maternal DM and obesity. Of these defects, those that are pertinent to structures derived 
from NCCs, and in particular CNCCs, include cataract/corneal opacity, orofacial clefts 
(Moore, Singer, Bradlee, Rothman, & Milunsky, 2000), and cranial nerve malformations 
(Cederberg, Picard, & Eriksson, 2003). It should be noted that these effects stem from 
neural tube closure defects (Moore et al., 2000). One group has suggested that fetuses of 
diabetic pregnancies sometimes express a collection of characteristics similar to those 
seen in DiGeorge anomaly. This includes low-set external ears, poorly formed Meckel’s 
cartilage, small thyroid and thymus, and the lack of a parathyroid gland. All of these 
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organs or structures contain cells that are derived from CNCCs. Also of note are cardiac 
issues in this constellation of features. This group suggests that the incidence of 
DiGeorge anomaly in diabetic pregnancies can be associated with the diabetes itself 
(Martin, Gittenberger-De Groot, Wisse, & Erikkson, 2000). Additionally, CarNCCs are 
also greatly affected, leading to septal closure defects (Moore et al., 2000) and outflow 
tract defects (Morgan, Relaix, Sandell, & Loeken, 2008). 
 While the mechanisms through which CNCCs and CarNCCs are affected by 
GDM are almost identical, much more research has been conducted in the area of 
CarNCCs and the associated congenital defects (Chan, Cheung, Yung, & Copp, 2004). 
Therefore, the intricacies of the mechanisms will be explained in the context of CarNCCs 
here. Hyperglycemia, through the associated oxidative stress, causes apoptosis of 
CarNCCs, resulting in defects in the outflow tract, the structure through which blood 
passes in the heart before exiting through the major arteries (Morgan et al., 2008). Like 
CNCCs, CarNCCs, migrate from the neural tube at the somite stage. Crucial to this 
migration is the Pax-3 transcription factor (Chan et al., 2004). Pax-3 is also required at 
the time of neural tube closure during embryological development, as it suppresses p53-
induced apoptosis, rather than modifying p53 gene expression (Pani, Horal, & Loeken, 
2002). In the embryos of diabetic pregnancies, Pax-3 is underexpressed. The mutant 
allele, called Splotch, contains a single base substitution that renders one of its DNA-
binding domains non-functional. Thus, the underexpression of Pax-3 results in higher 
levels of apoptosis (Phelan, Ito, & Loeken, 1997).  
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 Among the CNCC-derived structures affected by GDM, cranial nerve formation 
has been studied in diabetic rat models. Hyperglycemic environments were shown to 
cause cell death in CNCCs, impairing the development of cranial nerves V, VII, VIII, IX 
and X. This experiment also confirmed that hyperglycemic conditions caused a 
downregulation of Pax-3, inducing CNCC apoptosis. The experimenters in this study 
note that they did not examine whether this impairment in development was later 
recovered during development, as cranial nerves derive from CNCCs and ectodermal 
placode. Thus, the experimenters conclude that it is possible, at a later stage in 
development, that the ectodermal placode is able to compensate for the lack of CNCCs 
(Cederberg et al., 2003).   
 
Gestational Diabetes Screening and Diagnosis 
 The oral glucose tolerance test has long been in use to screen for GDM in 
pregnant women. Screening is normally done at 24-28 weeks of gestation. The test is 
performed after overnight fasting, and is done by administering 75g glucose dissolved in 
200-300ml of water orally. Plasma glucose levels are then measured after 2 hours. Based 
on the plasma glucose levels measured, patients should be diagnosed as having either 
“diabetes in pregnancy” or “gestational diabetes mellitus.” The term “diabetes in 
pregnancy” is reserved for more severe cases, while the term “gestational diabetes 
mellitus” can be used to describe patients who meet a lower threshold (World Health 
Organization, 2013). The values used in diagnosis are given in Table 4.   
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Table 4. Diagnostic values of gestational diabetes mellitus vs. diabetes in pregnancy. 
This table summarizes the diagnostic plasma glucose levels to differentiate between 
severity of hyperglycemia during pregnancy. Adapted from values listed in Diagnostic 
Criteria and Classification of Hyperglycaemia First Detected in Pregnancy (World 
Health Organization, 2013) 
 Gestational diabetes 
mellitus 
Diabetes in pregnancy 
Fasting plasma glucose 5.1-6.9mmol/l (92-
125mg/dl) 
≥7.0mmol/l (126mg/dl) 
2-hour plasma glucose ≥10.0mmol/l (180mg/dl) 
following 75g oral glucose 
dose 
≥11.1mmol/l (200mg/dl) 
following 75g oral glucose 
dose 
Random plasma glucose 8.5-11.0mmol/l (153-
199mg/dl) following 75g 
oral glucose dose 
≥11.1mmol/l (200mg/dl) in 
the presence of diabetes 
symptoms 
 
 
Similar testing is performed after the pregnancy ends, to re-evaluate if the case 
was one of GDM or type II diabetes mellitus. Women with risk factors for GDM should 
be tested earlier in their pregnancy (World Health Organization, 2013). The importance 
of the oral glucose tolerance test, and screening in general, has been reiterated in 
literature. One study found that universally screening all pregnant women, rather than 
only screening those with known risk factors, resulted in a 2.7% higher incidence of 
GDM (Griffin et al., 2001), suggesting that many cases are not recognized without 
screening. 
 While the oral glucose tolerance test remains the primary clinical method of 
diagnosis, other methods of testing are being studied in clinical trials. The oral glucose 
tolerance test has been criticized of being inconvenient for patients, requiring an 
overnight fast. Instead, many of these methods involve a blood draw, a procedure that is 
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already commonly done during pregnancy to test for other lab values. One such test 
includes measuring plasma sex-hormone binding globulin (SHBG) levels. Low levels of 
SHBG are often found in patients with polycystic ovary disease, and have been found to 
be associated with a higher risk of developing GDM (Veltman-Verhulst et al., 2010). 
Because of the inflammatory mechanisms known to cause GDM, inflammatory markers 
can also be used for diagnosis. TNF-α levels have been found to be elevated in patients 
11-13 weeks of gestation who were likely to develop GDM later in pregnancy 
(Syngelaki, Visser, Krithinakis, Wright, & Nicolaides, 2016). Blood HbA1C levels, 
commonly used in the diagnosis of diabetes in non-pregnant populations, have not been 
found to be as effective of an indicator of GDM. In non-pregnant populations, the 
threshold of HbA1C is 5.7%, whereas in pregnant populations, HbA1C levels above 
5.9% may be an indication of GDM (Hughes, Moore, Gullam, Mohamed, & Rowan, 
2014).  
 
Treatment, Management and Prevention of Gestational Diabetes Mellitus in 
Mothers  
 It has long been understood that women with GDM have a high likelihood of 
progressing to type 2 DM post-partum. However, studies have found that the risk can be 
decreased with healthy dietary habits (Tobias et al., 2012). GDM has also been found to 
increase the risk of cardiovascular disease and other comorbidities, especially in women 
with a family history of type 2 DM (Carr et al., 2006).  
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Due to the prevalence of GDM, its treatment options have been studied in great 
detail. The American Diabetes Association (ADA) has created “Standards of Medical 
Care in Diabetes,” a document that details treatment options in diabetes, and specifically 
in GDM. In addition to specifying when mothers should be screened, it also details 
glucose monitoring practices, and management options. Lifestyle management, through 
dietary habits, physical activity, and weight management are the first line of treatment. 
Beyond that, pharmaceutical treatment includes sulfonylureas, metformin, and insulin. 
According to the American Diabetes Association, insulin is the first recommended 
option, as it does not pass the blood-placenta barrier and affect the fetus (The American 
Diabetes Association, 2018). However, multiple studies have in fact shown that 
metformin is as effective, or possibly even more effective, than insulin in reducing serum 
glucose levels (Beyuo et al., 2015) and does not have any adverse outcomes on the 
development of the fetus (Tertti, Laine, Ekblad, Rinne, & Rönnemaa, 2014). Studies by 
the same group have even measured neurodevelopment outcomes of 2-year old children 
whose mothers were prescribed metformin during pregnancy, and found no adverse 
effects (Tertti, Eskola, Rönnemaa, & Haataja, 2015). Based on these findings, metformin 
alone can be used as an alternative to insulin in the treatment of GDM. This is of 
particular importance in developing countries where cheap and easily accessible therapies 
are of utmost importance (Ainuddin, Karim, Hasan, & Naqvi, 2015). 
Another potential therapy is the supplementation of vitamin D. While not yet 
completely understood, vitamin D supplementation in women with GDM has been shown 
to increase glucose tolerance and metabolism. Initially noticed in observational studies 
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(Rudnicki & Mølsted-Pedersen, 1997), the phenomenon has been further studied since. 
The mechanism is not yet completely understood, but further studies have shown that co-
treatment with vitamin D and omega-3 fatty acids leads to increased levels of serum 
vitamin D concentrations, which in turn promotes improved glycemic control and 
decreased serum triglyceride and VLDL-cholesterol levels (Jamilian et al., 2017).  
While treatment options are now abundant for patients with GDM, prevention of 
the disease is still the ideal way to avoid affecting the development of the fetus. Abundant 
research has been conducted in the field of maternal GDM prevention through lifestyle 
change. Initially conducted in Finland (Rönö et al., 2014), randomized control trials 
around the world have found mixed results in the benefits of an exercise regimen in 
preventing GDM. One study found that moderate-intensity exercise in the second and 
third trimesters could decrease some of the negative outcomes of GDM in both mother 
and fetus (Barakat, Pelaez, Lopez, Lucia, & Ruiz, 2013). Another study found no 
significant benefit in similar patient populations (Stafne et al., 2012). 
 
Treatment and Management of GDM-Induced Effects in the Fetus 
 It is now well understood that maternal hyperglycemia leads to fetal 
hyperglycemia, instigating a range of effects in the developing fetus. Management of 
maternal GDM is the primary method to minimize effects on fetal development. 
However, in cases that maternal GDM is not controlled, most of the fetal effects have 
been shown to be caused by the creation of oxidative stress, most likely from the 
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increased oxidation of glucose. In experiments, antioxidant enzymes such as SOD were 
shown to decrease the severity of congenital defects (Eriksson & Borg, 1993).  
Also shown to decrease the incidence of defects is the injection of arachidonic 
acid. The treatment with arachidonic acid is of particular interest to this discussion, as it 
was shown to decrease the incidence of cleft palate (Goldman et al., 1985), a congenital 
defect known to be associated with CNCCs. However, this is not yet a viable option as 
therapeutics. Therefore, antioxidant supplementation has been studied for many years. In 
one study, women with GDM were given varying doses of a combination therapy of 
vitamin E and vitamin C. Compared to women given the high-dose and untreated women, 
women given the low-dose showed intermediate rates of occurrence of malformations by 
preventing apoptosis. Women given the high-dose showed the greatest decrease in rates 
of occurrence. However, it should be noted that the combination therapy, administering 
both vitamins in one solution, was not more efficient than administering each of the 
vitamins alone. This indicates that the doses of each vitamin, rather than the overall 
molarity of antioxidants given, is most important to determining the level of results seen 
(Cederberg, Simán, & Eriksson, 2001). 
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CONCLUSION 
Embryology, Migration Patterns and Dysregulation of Cranial Neural Crest Cells  
 NCCs are a special group of cells that arise with neurulation during the early 
weeks of embryogenesis. Once NCCs break off from the neural tube, they divide into 
various subtypes, including CNCCs and CarNCCs. Each of these subtypes gives rise to a 
variety of structures throughout the fetus. For example, CNCCs give rise to craniofacial 
bone, parafollicular cells of the thyroid gland, connective tissues such as Meckel’s 
cartilage, the cornea, and some cranial nerves. CarNCCs give rise to the septa of the 
heart, the outflow tract, and other cardiac structures. The differentiation of these cells and 
their migration are extremely intricate processes that depend on tightly regulated gene 
expression mechanisms. Signaling pathways such as Shh allow for cells to differentiate 
appropriately.  
Also important to the development of NCC-derived structures is EMT. EMT is 
another process that is tightly regulated by signaling pathways such as Wnt, Notch, and 
more. It is characterized by two important steps – the loss of cellular polarity, and the 
detachment from neighboring cells via the downregulation of E-cadherins. EMT is 
crucial to the migration of NCCs, and is a common step along the pathway of NCC-
derived structure formation where problems can occur.  
Importantly, in order for gene expression and EMT to occur as expected, cells 
should be surrounded by ideal conditions. Without an environment in homeostasis, gene 
expression changes and NCCs undergo apoptosis. Depending on the stage of 
development at which cells undergo apoptosis, the effects on the fetus will vary. As such, 
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earlier exposures to teratogenic conditions leads to apoptosis in more primitive structures, 
leading to more drastic effects in the fully developed fetus.  
 
Comparison of Maternal Alcohol Consumption and Maternal Gestational Diabetes 
and their Effects on Cranial Neural Crest Cells 
 While the conditions under which maternal alcohol consumption and maternal 
GDM affect fetal development are very different, the similarities in the pathogenesis of 
their congenital defects is remarkably similar. The main mechanism through which 
CNCC or CarNCC structures are malformed is through apoptosis. NCCs undergo 
apoptosis when vital genes are no longer expressed properly. The main mechanism 
through which cells were affected in both cases of maternal alcohol consumption and 
cases of GDM was through oxidative stress. The generation of reactive oxygen species is 
extremely harmful to the health of the cell. Without an adequate antioxidant response, 
cells are unable to handle the stress that free radicals generate, and apoptotic pathways 
are triggered. In the case of maternal alcohol consumption, Bcl-2 levels dropped and p53 
expression increased, leading to cell apoptosis. In the case of GDM, Pax-3 was 
downregulated, leading to less suppression of p53-induced apoptosis.  
While the end mechanism through which cells ultimately underwent apoptosis is 
similar, what is of most interest is the mechanism by which cells reached that point in 
each of these pathogenic processes. In cases of maternal alcohol consumption, ethanol 
metabolism leads to the depletion of NADH, leading to increased release of iron from its 
stores. Iron, in turn, leads to the generation of free hydroxyl radicals. In the case of 
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maternal GDM, increased glucose levels lead to increased glucose metabolism, which 
causes increased amounts of oxidative phosphorylation to occur. As a byproduct, 
increased levels of reactive oxygen species are generated. In both cases, apoptosis is 
triggered by the generation of reactive oxygen species, such as free hydroxyl radicals.  
Because of the similar pathologies, both conditions are treated in very similar 
ways. Antioxidants are the primary therapy in decreasing reactive oxygen species, and 
thus preventing NCC apoptosis. Studies in fetal alcohol syndrome have looked at 
compounds such as sulforaphane, found in broccoli and similar vegetables. Its 
mechanism as an antioxidant decreases the formation of reactive oxygen species. Studies 
in maternal GDM cases have looked at vitamin supplementations, such as vitamin C and 
E to reduce reactive oxygen species generation and vitamin D with omega-3 fatty acids to 
reduce serum triglyceride levels.  
It is of great interest that maternal alcohol consumption and maternal GDM can 
result in similar conditions in the fetus. While fetal alcohol syndrome has a collection of 
symptoms that can be grouped together, congenital defects associated with maternal 
GDM are not as straightforward. Cardiac defects are extremely common, and one study 
suggests that the constellation of symptoms known as the DiGeorge anomaly can often be 
attributed to GDM. Regardless of the name given to the group of symptoms seen in the 
fetus, what is remarkable is the amount of overlap between the two conditions. 
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Public Health Implications 
 Congenital defects in NCC-derived structures can have grave implications in 
patients’ lives. Craniofacial abnormalities can have consequences on the function of the 
structures, but can also mean a lifetime of social insecurities. Cardiac defects in the 
outflow tract can lead to severe debilitation, as can abnormalities in thyroid or 
parathyroid gland structure. However, these congenital defects can largely be prevented 
through the maintenance of maternal health. As such, keen attention should be paid to 
keeping mothers healthy when they are conceiving and during gestation (Brown, 2016).  
 One of the most thorough ways to do so is through adequate prenatal care. 
Women should ideally have regular access to an obstetrician who can screen for various 
conditions and manage treatment options if necessary. Prenatal screenings, including 
those that measure the likelihood of risk drinking during pregnancy, such as TWEAK, 
and those that are used to diagnose GDM, such as the oral glucose tolerance test, should 
be done at appropriate points either prior to conceiving (Russell, 1994), or at about 24-28 
weeks of gestation (The American Diabetes Association, 2018), respectively. In the case 
that treatment is needed, regular follow-up with a clinician is important to properly 
regulating the therapy. However, the reality is that many women, both internationally and 
domestically, are unable to access a physician with frequency (Loveland Cook, Selig, 
Wedge, & Gohn-Baube, 1999), or pay for many therapies (Pathak, Singh, & 
Subramanian, 2010). Thus, these conditions become serious public health concerns. 
While groups such as the World Health Organization and the American Diabetes 
Association frequently release literature that determines the guidelines of screening and 
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therapy, the reality is that healthcare access is still a large concern for many women. 
Thus, service organizations throughout the world should continue to identify these issues 
and find innovative ways to provide healthcare to women of all socioeconomic statuses 
all over the world.  
 
Future Directions 
 Current research in the fields of fetal alcohol exposure and maternal GDM-
induced hyperglycemia exposure has mostly been in understanding the mechanism of 
pathogenesis. The biochemical processes that lead to cell apoptosis, and thus congenital 
defects, have been elicited in great detail as a combined effort by research groups around 
the world. By understanding the mechanisms, scientists are able to identify the exact risks 
that mothers and their fetuses encounter in high-risk pregnancies.  
 Research has also begun to identify an assortment of treatment options for these 
conditions. Armed with a thorough understanding of how NCC processes go awry, 
researchers have been able to assess which therapies might improve congenital outcomes. 
However, these therapies are still not always viable from a patient standpoint. Those that 
have proven to be most effective in the lab, such as the addition of SOD, are not possible 
treatments in the clinic. Supplementation with vitamins and other such compounds is 
possible, but is not always effective in completely preventing any symptoms in the fetus.  
 Thus, future directions in this field of study should be to identify treatment 
options that are viable in the field. When considering communities of lower 
socioeconomic backgrounds, or international communities that have few resources, it is 
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important to design therapies that are cost-effective and easily accessible. Future research 
should come from a public health and pharmaceutical standpoint, focusing on creating 
affordable and effective therapeutics.  
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